The Trump administration is withdrawing a proposal to overhaul drug rebates in Medicare and Medicaid as part of efforts to lower prescription drug costs after "careful analysis and thorough consideration," according to White House spokesman Judd Deere. The administration remains focused on other ideas to manage prescription drug costs, such as tying prices to those in other countries and potentially an inflation cap.
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.